The effects of midodrine on patients with liver cirrhosis and refractory ascites: a randomized controlled trial
Background: Splanchnic vasodilation is a significant contributor to the development of ascites in cirrhotic patients. So, midodrine, an alpha-one agonist, may improve circulatory abnormality in cirrhotic patients via its vasoconstrictive action, thus lessening refractory ascites.Aim: To assess the e...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
african journal of gastroenterology and hepatology
2023-11-01
|
| Col·lecció: | African Journal of Gastroenterology and Hepatology |
| Matèries: | |
| Accés en línia: | https://ajgh.journals.ekb.eg/article_325751_8bad6c7e00932478283d46e9659448ec.pdf |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|